Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | trofinetide (Daybue, Daybue Stix)PayerPolicy · BCBSLA-46B9BAC1-C72D-4CD4-AD7A-9D03BED24F77-8DF7E03D06 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00839 Accrufer (ferric maltol)PayerPolicy · BCBSLA-00839-21A7FEECE6 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00838 ublituximab (Briumvi)PayerPolicy · BCBSLA-00838-96BB0D5741 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00837 elivaldogene autotemcel (Skysona)PayerPolicy · BCBSLA-00837-DF3E2C2A20 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00835 adalimumab BiosimilarsPayerPolicy · BCBSLA-00835-1F43CC573D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00834 Select External Insulin Infusion Pumps (Omnipod Pods)PayerPolicy · BCBSLA-00834-9111AB2907 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00833 Noxafil PowderMix (posaconazole delayed-release oral suspension)PayerPolicy · BCBSLA-00833-521A266D9F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00832 Novel Loop Diuretic FormulationsPayerPolicy · BCBSLA-00832-11737B8A51 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00831 sodium phenylbutyrate/taurursodiol (Relyvrio)- Retired PolicyPayerPolicy · BCBSLA-00831-6FFB7FAD91 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00830 Auvelity (dextromethorphan/bupropion)PayerPolicy · BCBSLA-00830-2C99D769AC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00829 Non-Invasive Home Mechanical VentilationPayerPolicy · BCBSLA-00829-D6255D5897 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00828 cabotegravir intramuscular injection (Apretude)PayerPolicy · BCBSLA-00828-A7CB1680CC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00827 Zoryve (roflumilast)PayerPolicy · BCBSLA-00827-264DE3B0BB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00826 Genetic Testing for Fanconi Anemia- Retired PolicyPayerPolicy · BCBSLA-00826-621BF7B71B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00825 Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic HyperplasiaPayerPolicy · BCBSLA-00825-1624B73819 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00824 Select Drugs for the Treatment of Dementia of Alzheimer’s DiseasePayerPolicy · BCBSLA-00824-E84BE15DD0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00823 betibeglogene autotemcel (Zynteglo)PayerPolicy · BCBSLA-00823-588B6ECE03 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00822 Select Hemophilia A ProductsPayerPolicy · BCBSLA-00822-0C0344B54E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00821 Transanal Endoscopic MicrosurgeryPayerPolicy · BCBSLA-00821-6CA2CE1EAB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00820 Lanreotide ProductsPayerPolicy · BCBSLA-00820-A1DAB0AE0A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00819 Granulocyte Colony Stimulating Factor (G-CSF) ProductsPayerPolicy · BCBSLA-00819-AA8F2A605E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00818 Trastuzumab ProductsPayerPolicy · BCBSLA-00818-AAB6B6C577 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00817 Bevacizumab ProductsPayerPolicy · BCBSLA-00817-E149692221 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00816 Applied Behavior Analysis for Autism Spectrum DisorderPayerPolicy · BCBSLA-00816-4B742B622F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00815 Entadfi (finasteride and tadalafil)PayerPolicy · BCBSLA-00815-52F84741A3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00814 Vivjoa (oteseconazole)PayerPolicy · BCBSLA-00814-38488A3B73 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00813 sirolimus topical gel (Hyftor)PayerPolicy · BCBSLA-00813-A52B398596 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00812 mavacamten (Camzyos)PayerPolicy · BCBSLA-00812-5B820493E8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00811 deucravacitinib (Sotyktu)PayerPolicy · BCBSLA-00811-D99457692F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00808 Noncontact Ultrasound Treatment for WoundsPayerPolicy · BCBSLA-00808-EAEF0F9212 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00807 difelikefalin (Korsuva)PayerPolicy · BCBSLA-00807-58574C11B4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00806 Surgical Left Atrial Appendage Occlusion for Stroke Prevention in Atrial FibrillationPayerPolicy · BCBSLA-00806-7A2BCF30C5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00805 Select Vascular Endothelial Growth Factor (VEGF) Inhibitors and Combination ProductsPayerPolicy · BCBSLA-00805-C5F9A22BFC | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00804 Vtama (tapinarof)PayerPolicy · BCBSLA-00804-6CD7701EB5 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00803 alpelisib (Vijoice)PayerPolicy · BCBSLA-00803-3A9AB2A972 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00802 Verkazia (cyclosporine ophthalmic emulsion)PayerPolicy · BCBSLA-00802-1FF1F8E9A7 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00801 plasminogen, human-tvmh (Ryplazim)PayerPolicy · BCBSLA-00801-D1B80D4DDF | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00800 sutimlimab-jome (Enjaymo)PayerPolicy · BCBSLA-00800-FFD08C0D9E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00799 mitapivat (Pyrukynd)PayerPolicy · BCBSLA-00799-29A91DC11F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00798 budesonide delayed release (Tarpeyo)PayerPolicy · BCBSLA-00798-A8324E3320 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00797 Remote Electrical Neuromodulation for MigrainesPayerPolicy · BCBSLA-00797-51B0EEF2EB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00796 tralokinumab-ldrm (Adbry)PayerPolicy · BCBSLA-00796-5EACE4136F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00795 abrocitinib (Cibinqo)PayerPolicy · BCBSLA-00795-DBC7DFEC00 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00794 Soaanz (torsemide tablets)PayerPolicy · BCBSLA-00794-61B885D203 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00793 Nexiclon XR (clonidine extended release tablets)PayerPolicy · BCBSLA-00793-7E3FDAE8B3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00792 Tumor-Informed and Tumor-Agnostic (Plasma-Only) Circulating Tumor DNA Minimal Residual Disease (MRD) Detection for Cancer Management- Retired PolicyPayerPolicy · BCBSLA-00792-AC4CDD1BD8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00791 Select Carbidopa/Levodopa ProductsPayerPolicy · BCBSLA-00791-11E67492DE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00790 efgartigimod alfa (Vyvgart), efgartigimod alfa and hyaluronidase- human (Vyvgart Hytrulo)PayerPolicy · BCBSLA-00790-C708843DC8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00789 levoketoconazole (Recorlev)PayerPolicy · BCBSLA-00789-6C7AD28735 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00788 tezepelumab-ekko (Tezspire)PayerPolicy · BCBSLA-00788-16EAC12ACE | New policy |
|---|